celiprolol has been researched along with Death, Sudden in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uprichard, AC | 1 |
| Chi, LG | 1 |
| Kitzen, JM | 1 |
| Lynch, JJ | 1 |
| Frye, JW | 1 |
| Lucchesi, BR | 1 |
1 other study available for celiprolol and Death, Sudden
| Article | Year |
|---|---|
Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Celiprolol; Death, Sudden; Dogs; Elect | 1989 |